{"filing":{"accession_number":"0001104659-26-085900","cik":"0001533998","ticker":"DRIO","company_name":"DarioHealth Corp.","form":"8-K","filing_date":"2026-07-22","report_date":null,"primary_document":"tm2621105d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926085900/tm2621105d1_8k.htm"},"events":[{"id":19682,"run_id":17708,"accession_number":"0001104659-26-085900","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"DarioHealth entered into a Securities Purchase Agreement on July 22, 2026, to issue 2,437,060 shares of common stock and 1,017,499 pre-funded warrants in a registered direct offering at $6.80 per share, raising approximately $23.5 million in gross proceeds. This registered direct offering dilutes existing shareholders and represents a significant capital raise.","company_name":"DarioHealth Corp.","ticker":"DRIO","filing_date":"2026-07-22","form":"8-K","submitted_at":null,"items":[{"id":18846,"accession_number":"0001104659-26-085900","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"DarioHealth entered into a Securities Purchase Agreement on July 22, 2026, to issue 2,437,060 shares of common stock and 1,017,499 pre-funded warrants in a registered direct offering at $6.80 per share, raising approximately $23.5 million in gross proceeds. This is a registered direct offering of equity securities that will dilute existing shareholders, fitting the definition of dilutive_issuance. The transaction is material as it represents a significant capital raise and equity dilution event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T21:20:14.874655+00:00","company_name":"","ticker":null,"filing_date":""},{"id":18847,"accession_number":"0001104659-26-085900","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"DarioHealth announced a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, raising approximately $23.5 million gross proceeds. This is a registered equity issuance that dilutes existing shareholders. The offering was priced at-the-market under Nasdaq rules and involved both existing institutional investors and new investors, with a board member also participating. This is a material capital-raising event typical of dilutive equity issuances disclosed under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T21:20:14.874655+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18846,"accession_number":"0001104659-26-085900","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"DarioHealth entered into a Securities Purchase Agreement on July 22, 2026, to issue 2,437,060 shares of common stock and 1,017,499 pre-funded warrants in a registered direct offering at $6.80 per share, raising approximately $23.5 million in gross proceeds. This is a registered direct offering of equity securities that will dilute existing shareholders, fitting the definition of dilutive_issuance. The transaction is material as it represents a significant capital raise and equity dilution event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T21:20:14.874655+00:00","company_name":"DarioHealth Corp.","ticker":"DRIO","filing_date":"2026-07-22"},{"id":18847,"accession_number":"0001104659-26-085900","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"DarioHealth announced a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, raising approximately $23.5 million gross proceeds. This is a registered equity issuance that dilutes existing shareholders. The offering was priced at-the-market under Nasdaq rules and involved both existing institutional investors and new investors, with a board member also participating. This is a material capital-raising event typical of dilutive equity issuances disclosed under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T21:20:14.874655+00:00","company_name":"DarioHealth Corp.","ticker":"DRIO","filing_date":"2026-07-22"}]}